Pulmonary infections with Mycobacterium xenopi in patients without HIV infection;Les infections pulmonaires à Mycobacterium xenopi en dehors du VIH/SIDA: Étude rétrospective sur dix cas

Revue des Maladies Respiratoires

Volumn 24, Issue 3, 2007, Pages 299-304

  Dixmier, A ^a   Meynard, J L ^a   Lalande, V ^a   Lebeau, B ^a   Chouaid C ^a,b  

^a HÔPITAL SAINT ANTOINE   (France)

^b Service de Pneumologie   (France)

Author keywords

Antituberculous; Mycobacteriosis; Mycobacterium xenopi

Indexed keywords

CLARITHROMYCIN; ETHAMBUTOL; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ACID FAST BACTERIUM; ADULT; AGED; ALCOHOLISM; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM DETECTION; CANCER; CHRONIC DISEASE; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LUNG INFECTION; LUNG SURGERY; LUNG TUBERCULOSIS; MALE; MICROBIOLOGY; MYCOBACTERIOSIS; MYCOBACTERIUM XENOPEI; OUTCOME ASSESSMENT; RADIODIAGNOSIS; SEROLOGY; STEROID THERAPY; SYSTEMIC THERAPY; TIME OF DEATH; TREATMENT DURATION; UNIVERSITY HOSPITAL;

EID: 34247159637     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0761-8425(07)91061-x     Document Type: Article

References (23)

1. Delaunois L, Garrino MG : Manifestations, diagnostic et traitement des infections mycobacteries non-tuberculeuses chez les patients non immunodéprimés. Rev Mal Respir 1997 ; 14 : S130-41.
2. Thaunat O, Morelon E, Stern M, Buffet P, Offredo C, Mamzer-Bruneel MF, Kreis H : Mycobacterium xenopi pulmonary infection in two renal transplant recipients under sirolimus therapy. Transpl Infect Dis 2004 ; 6 : 179-82.
3. Dailloux M, Albert M, Laurain C, Andolfatto S, Lozniewski A, Hartemann P, Mathieu L : Mycobacterium xenopi and drinking water biofilms. Appl Environ Microbiol 2003 ; 69 : 6946-8.
4. Dauendorffer JN, Laurain C, Weber M, Dailloux M : Mycobacterium xenopi : épidémiologie et caractéristiques bactériologiques. Ann Biol Clin 2001 ; 59 : 123-30.
5. Thomsen VO, Andersen AB, Miorner H : Incidence and clinical significance of non-tuberculous mycobacteria isolated from clinical specimens during a 2-y nationwide survey. Scand J Infect Dis 2002 ; 34 : 648-53.
6. Decludt B, Trystram D, Vinvent V, Truffot-Pernot C, Boulahbal F, Robert J, Botherel AH, Peronne C, Grosset J : Infections à Mycobacterium xenopi en France. BEH 2000 ; 17 : 71-2.
7. Heginbothom ML : The relationship between the in vitro drug susceptibility of opportunist mycobacteria and their in vivo response to treatment. Int J Tuberc Lung Dis 2001 ; 5 : 539-45.
8. American thoracic Society : diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 1997 ; 156 : S1-S25.
9. Froidure M, Massin F, Duez JM, Baudouin N, Camus P, Jeannin L : Infections pulmonaires à Mycobacterium xenopi excluant les SIDA. À propos de 8 cas. Rev Mal Respir 2000 ; 17 : 481-7.
10. Jenkins PA, Campbell IA : Research Committee of The British Thoracic SocietyPulmonary disease caused by Mycobacterium xenopi in HIV-negative patients: five year follow-up of patients receiving standardised treatment. Respir Med 2003 ; 97 : 439-44.
11. Majoor CJ, Schreurs AJ, Weers-Pothoff G : Mycobacterium xenopi infection in an immunosuppressed patient with Crohn's disease. Thorax 2004 ; 59 : 631-2.
12. Smith MJ, Citron KM : Clinical review of pulmonary disease caused by Mycobacterium xenopi. Thorax 1983 ; 38 : 373-7.
13. Al Jarad N, Demertzis P, Jones DJ, Barnes NC, Rudd RM, Gaya H, Wedzicha JA, Hughes DT, Empey DW: Comparison of characteristics of patients and treatment outcome for pulmonary non-tuberculous mycobacterial infection and pulmonary tuberculosis. Thorax 1996 ; 51 : 137-9.
14. Research Committee of the British Thoracic Society. First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol. Thorax 2001 ; 56 : 167-72.
15. Baugnee PE, Pouthier F, Delaunois L : Mycobacteriose pulmonaire due à Mycobacterium xenopi" : in-vitro sensibilité aux antituberculeux classiques et évolution clinique. Acta Clin Belg 1996 ; 51 : 19-27.
16. Management of opportunist Mycobacterial infections: Joint tuberculosis committe guidelines 1999. Thorax 2000 ; 55 : 210-8.
17. Schmitt H, Schnitzler N, Riehl J, Adam G, Sieberth HG, Haase G : Successful treatment of pulmonary Mycobacterium xenopi infection in a natural killer cell-deficient patient with clarithromycin, rifabutin, and sparfloxacin. Clin Infect Dis 1999 ; 29 : 120-4.
18. Grosset J, Truffot-Pernot C : Mycobacterium xenopi : un nouveau venu ? Rev Prat 1998 ; 48 : 701-3.
19. Lang-Lazdunski L, Offredo C, Le Pimpec-Barthes F, Danel C, Dujon A, Riquet M.Pulmonary resection for Mycobacterium xenopi pulmonary infection. Ann Thorac Surg 2001 ; 72 : 1877-82.
20. Bellamy J, Leroy-Terquem E, Duhamel JP, Choffel C, Fraboulet G, Tobelem G, Verdoux P : Infection à Mycobacterium xenopi avec emphyseme bulleux. Apropos of 4 cas operas. Rev Mal Respir 1987 ; 4 : 261-4.
21. Banks J, Hunter AM, Campbell IA, Jenkins PA, Smith AP : Pulmonary infection with mycobacterium xenopi : review of treatment and response. Thorax 1984 ; 39 : 376-82.
22. Sherwood JT, Mitchell JD, Pomerantz M : Completion pneumonectomy for chronic mycobacterial disease. J Thorac Cardiovasc Surg 2005 ; 129 : 1258-65.
23. Parrot RG, Grosset JH : Post-surgical outcome of 57 patients with Mycobacterium xenopi pulmonary infection. Tubercle 1988 ; 69 : 47-55.